[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6635 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 6635

 To prohibit the Department of Health and Human Services from treating 
   pregnancy as an illness for purposes of approving abortion drugs.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            December 6, 2023

    Mrs. Miller of Illinois (for herself, Mr. Moore of Alabama, Mr. 
  LaMalfa, and Ms. Boebert) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To prohibit the Department of Health and Human Services from treating 
   pregnancy as an illness for purposes of approving abortion drugs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pregnancy Is Not an Illness Act of 
2023''.

SEC. 2. PROHIBITION AGAINST TREATING PREGNANCY AS ILLNESS FOR PURPOSES 
              OF APPROVING ABORTION DRUGS.

    (a) Prohibition.--The Department of Health and Human Services, 
including the Food and Drug Administration, shall not treat pregnancy 
as an illness for purposes of--
            (1) approving any abortion drug under section 505 of the 
        Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355); or
            (2) imposing or maintaining any risk evaluation and 
        mitigation strategy for an abortion drug under section 505-1 of 
        such Act (21 U.S.C. 355-1).
    (b) Nullification of Approvals in Effect.--
            (1) In general.--Any prohibited approval of an abortion 
        drug is hereby nullified.
            (2) Prohibited approval defined.--In this subsection, the 
        term ``prohibited approval of an abortion drug''--
                    (A) means any approval of an abortion drug under 
                section 505 of the Federal Food, Drug, and Cosmetic Act 
                (21 U.S.C. 355) that relied in whole or in part on the 
                treatment of pregnancy as illness; and
                    (B) includes the approval of mifepristone in effect 
                under such section 505 on the day before the date of 
                enactment of this Act.
                                 <all>